View Older Stories View More Recent Stories
-
Form SC 13G Teligent, Inc. Filed by: Broadfin Capital, LLC
-
Form SC 13D/A BIODELIVERY SCIENCES Filed by: Broadfin Capital, LLC
-
Form SC 13G Adamas Pharmaceuticals Filed by: Broadfin Capital, LLC
-
Form SC 13D BIODELIVERY SCIENCES Filed by: Broadfin Capital, LLC
-
STRATA Skin Sciences (SSKN) Reports $17M Equity Financing led by Accelmed Growth Partners; Announces Dr. Doley Rafaeli as Interim CEO
-
STRATA Skin Sciences Announces $17 Million Equity Financing led by Accelmed Growth Partners; Appointment of Industry Veteran as Interim CEO
-
Form SC 13D/A NOVELION THERAPEUTICS Filed by: Broadfin Capital, LLC
-
Novelion Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results
-
Novelion Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results
-
Novelion Therapeutics Subsidiary Enters into $20 Million Term Loan Agreement with Sarissa Capital and Broadfin Capital
-
Novelion Therapeutics Subsidiary Enters into $20 Million Term Loan Agreement with Sarissa Capital and Broadfin Capital
-
Form SC 13D/A Recro Pharma, Inc. Filed by: Broadfin Capital, LLC
-
Form SC 13G/A DEXTERA SURGICAL INC Filed by: Broadfin Capital, LLC
-
Form SC 13G/A SeaSpine Holdings Corp Filed by: Broadfin Capital, LLC
-
Form SC 13G/A ADMA BIOLOGICS, INC. Filed by: Broadfin Capital, LLC
-
Form SC 13G/A PROGENICS PHARMACEUTICAL Filed by: Broadfin Capital, LLC
-
Form SC 13G/A CONTRAFECT Corp Filed by: Broadfin Capital, LLC
-
Form SC 13G/A Retrophin, Inc. Filed by: Broadfin Capital, LLC
-
Form SC 13G/A WINDTREE THERAPEUTICS Filed by: Broadfin Capital, LLC
-
Form SC 13G/A Alphatec Holdings, Inc. Filed by: Broadfin Capital, LLC
-
Form SC 13G/A Corium International, Filed by: Broadfin Capital, LLC
-
Form SC 13G/A Ignyta, Inc. Filed by: Broadfin Capital, LLC
-
Form SC 13G/A DURECT CORP Filed by: Broadfin Capital, LLC
-
Form SC 13G/A VERACYTE, INC. Filed by: Broadfin Capital, LLC
-
Form SC 13G/A Strongbridge Biopharma Filed by: Broadfin Capital, LLC
-
Form SC 13G/A HERON THERAPEUTICS, INC. Filed by: Broadfin Capital, LLC
-
Form SC 13G IOVANCE BIOTHERAPEUTICS, Filed by: Broadfin Capital, LLC
-
Form SC 13G/A Aevi Genomic Medicine, Filed by: Broadfin Capital, LLC
-
Form SC 13G/A Mirati Therapeutics, Filed by: Broadfin Capital, LLC
-
Form SC 13G/A Aviragen Therapeutics, Filed by: Broadfin Capital, LLC
-
Form SC 13G/A Cidara Therapeutics, Filed by: Broadfin Capital, LLC
-
Form SC 13G/A ANTARES PHARMA, INC. Filed by: Broadfin Capital, LLC
-
Form SC 13G/A Nexvet Biopharma plc Filed by: Broadfin Capital, LLC
-
Form SC 13G/A CATALYST PHARMACEUTICALS Filed by: Broadfin Capital, LLC
-
Form SC 13G/A SCYNEXIS INC Filed by: Broadfin Capital, LLC
-
Form SC 13G/A BIODELIVERY SCIENCES Filed by: Broadfin Capital, LLC
-
Form SC 13G/A TENAX THERAPEUTICS, INC. Filed by: Broadfin Capital, LLC
-
Form SC 13G Arcturus Therapeutics Filed by: Broadfin Capital, LLC
-
Form SC 13G/A Regulus Therapeutics Filed by: Broadfin Capital, LLC
-
Form SC 13G/A AVADEL PHARMACEUTICALS Filed by: Broadfin Capital, LLC
-
Form SC 13G/A ARATANA THERAPEUTICS, Filed by: Broadfin Capital, LLC
-
Form SC 13G/A Aralez Pharmaceuticals Filed by: Broadfin Capital, LLC
-
Form 13F-HR Broadfin Capital, LLC For: Dec 31
-
Form SC 13G/A LA JOLLA PHARMACEUTICAL Filed by: Broadfin Capital, LLC
-
Form SC 13G LA JOLLA PHARMACEUTICAL Filed by: Broadfin Capital, LLC
-
Form SC 13G Egalet Corp Filed by: Broadfin Capital, LLC
-
Form SC 13D/A Recro Pharma, Inc. Filed by: Broadfin Capital, LLC
-
Form SC 13D/A Recro Pharma, Inc. Filed by: Broadfin Capital, LLC
-
Form SC 13D/A Recro Pharma, Inc. Filed by: Broadfin Capital, LLC
-
Form SC 13G/A Mirati Therapeutics, Filed by: Broadfin Capital, LLC

